Arteriocyte

Arteriocyte is a clinical-stage biotechnology company developing stem cell- and tissue engineering-based therapies. It provides platelet-rich plasma processing, automated umbilical cord blood processing, autologous stem cell therapy, allogeneic stem cell therapy, cell delivery and localization, protein co-delivery, cell expansion, and therapeutic angiogenesis-based solutions. The company also offers an autologous platelet separation system, sterile disposable supplies, demineralized bone matrix powder and demineralized bone matrix gel, as well as a hematopoietic stem cell expansion kit for research applications. Additionally, it develops cell therapy and tissue engineering technologies for cardiovascular, orthopedic, and vascular applications, as well as diabetic complications. It also provides cell culture products and technologies, such as cell culture and expansion kits and bags, along with cell culture supplements for translational research. Furthermore, the company's research areas include blood pharmaceutics, myocardial ischemia, critical limb ischemia, malaria research, orthopedic regenerative medicine, proliferative diabetic retinopathy, and wound healing.